Continuing education courses offered for physicians
The following educational opportunities are jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC, working in collaboration with the National Organization for Rare Disorders, Inc. (NORD) and the Immune Deficiency Foundation (IDF).
Read MoreCongenital athymia diagnosis begins at newborn screening
Learn how congenital athymia is diagnosed and treated, and what causes this rare immunodeficiency by tuning into "Congenital Athymia 101," an IDF forum presented by Dr. Elena Hsieh, University of Colorado School of Medicine Associate Professor of Pediatrics, Section of Allergy and Immunology, and Department of Immunology and Microbiology Director
Read MoreStudy finds CGD carriers exhibit symptoms of disorder
A chronic granulomatous disease (CGD) carrier study that involved the Chronic Granulomatous Disease Association of America (CGDAA) and the Primary Immune Deficiency Treatment Consortium (PIDTC) shows that female CGD carriers suffer from the same symptoms as those diagnosed with the disorder and recommends that CGD carriers seek diagnosis and
Read MoreWhy laboratory-developed tests’ fate matters for rare disease patients
Laboratory-developed tests (LDTs) fill an important niche in rare disease testing and newborn screening. Efforts via the VALID Act to put LDTs under FDA regulation could hurt patient access to innovative and specialized medical testing.
Read MoreDonor Spotlight: London
At 18 months old, London was diagnosed with Transient Hypogammaglobulinemia of Infancy (THI) and placed on monthly IVIG, but her symptoms didn’t improve. After connecting with the Immune Deficiency Foundation, the family was directed to Dr.
Read More
